These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
513 related articles for article (PubMed ID: 30570657)
1. Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era. Morton LM; Dores GM; Schonfeld SJ; Linet MS; Sigel BS; Lam CJK; Tucker MA; Curtis RE JAMA Oncol; 2019 Mar; 5(3):318-325. PubMed ID: 30570657 [TBL] [Abstract][Full Text] [Related]
2. Therapy-related acute myeloid leukaemia and myelodysplastic syndrome in Victoria, Australia 2003-2014. Ong DM; Farrugia H; Wei A Intern Med J; 2018 Jul; 48(7):822-829. PubMed ID: 29236346 [TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714 [TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk. Patt DA; Duan Z; Fang S; Hortobagyi GN; Giordano SH J Clin Oncol; 2007 Sep; 25(25):3871-6. PubMed ID: 17664457 [TBL] [Abstract][Full Text] [Related]
6. Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma. Gruschkus SK; Lairson D; Dunn JK; Risser J; Du XL Cancer; 2010 Nov; 116(22):5279-89. PubMed ID: 20665502 [TBL] [Abstract][Full Text] [Related]
7. Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem. Latagliata R; Petti MC; Fenu S; Mancini M; Spiriti MA; Breccia M; Brunetti GA; Avvisati G; Lo Coco F; Mandelli F Blood; 2002 Feb; 99(3):822-4. PubMed ID: 11806982 [TBL] [Abstract][Full Text] [Related]
8. Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States. Shenolikar R; Durden E; Meyer N; Lenhart G; Moore K Gynecol Oncol; 2018 Nov; 151(2):190-195. PubMed ID: 30268525 [TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population-based study among older breast cancer patients. Rosenstock AS; Niu J; Giordano SH; Zhao H; Wolff AC; Chavez-MacGregor M Cancer; 2018 Mar; 124(5):899-906. PubMed ID: 29236294 [TBL] [Abstract][Full Text] [Related]
10. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors. Kaplan HG; Malmgren JA; Li CI; Calip GS Breast Cancer Res Treat; 2013 Dec; 142(3):629-36. PubMed ID: 24265034 [TBL] [Abstract][Full Text] [Related]
11. Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab. Bennett JM; Kaminski MS; Leonard JP; Vose JM; Zelenetz AD; Knox SJ; Horning S; Press OW; Radford JA; Kroll SM; Capizzi RL Blood; 2005 Jun; 105(12):4576-82. PubMed ID: 15731177 [TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony-stimulating factors in older patients with non-Hodgkin lymphoma. Calip GS; Moran KM; Sweiss KI; Patel PR; Wu Z; Adimadhyam S; Lee TA; Ko NY; Quigley JG; Chiu BC Cancer; 2019 Apr; 125(7):1143-1154. PubMed ID: 30548485 [TBL] [Abstract][Full Text] [Related]
13. Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases. Merlat A; Lai JL; Sterkers Y; Demory JL; Bauters F; Preudhomme C; Fenaux P Leukemia; 1999 Feb; 13(2):250-7. PubMed ID: 10025899 [TBL] [Abstract][Full Text] [Related]
14. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience. Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450 [TBL] [Abstract][Full Text] [Related]
15. Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014. Teepen JC; Curtis RE; Dores GM; Berrington de Gonzalez A; van den Heuvel-Eibrink MM; Kremer LCM; Gilbert ES; van Leeuwen FE; Ronckers CM; Morton LM Leukemia; 2018 Dec; 32(12):2580-2589. PubMed ID: 29795414 [TBL] [Abstract][Full Text] [Related]
16. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs. Meyers J; Yu Y; Kaye JA; Davis KL Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706 [TBL] [Abstract][Full Text] [Related]
17. Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005. Kaplan HG; Malmgren JA; Atwood MK BMC Cancer; 2011 Jun; 11():260. PubMed ID: 21693006 [TBL] [Abstract][Full Text] [Related]
18. Trends in risk for therapy-related myelodysplastic syndrome/acute myeloid leukemia after initial chemo/immunotherapy for common and rare lymphoid neoplasms, 2000-2018. Morton LM; Curtis RE; Linet MS; Schonfeld SJ; Advani PG; Dalal NH; Sasse EC; Dores GM EClinicalMedicine; 2023 Jul; 61():102060. PubMed ID: 37457112 [TBL] [Abstract][Full Text] [Related]
20. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study. Kaplan H; Malmgren J; De Roos AJ Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]